Nexgenrx Inc (NXG.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 313 | 323 | 314 | 316 | 310 |
| Income taxes - deferred | -23 | -23 | -23 | 433 | -23 |
| Accounts receivable | -182 | 298 | -166 | 306 | -293 |
| Accounts payable and accrued liabilities | 216 | 112 | -350 | N/A | N/A |
| Other Working Capital | -7 | 413 | -476 | -490 | -313 |
| Other Operating Activity | 563 | -83 | 1,053 | -324 | 452 |
| Operating Cash Flow | $881 | $1,040 | $353 | $241 | $132 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -4 | -258 | -34 | -29 | -8 |
| Purchase Sale Intangibles | -14 | -83 | -21 | -71 | -60 |
| Other Investing Activity | -38 | -38 | -40 | -181 | 0 |
| Investing Cash Flow | $-56 | $-379 | $-96 | $-280 | $-67 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -29 | -34 | -34 | -31 | -26 |
| Common Stock Issued | 0 | 0 | 0 | 0 | 63 |
| Dividend Paid | -389 | -389 | -33 | -69 | -66 |
| Financing Cash Flow | $-417 | $-423 | $-67 | $-100 | $-30 |
| Beginning Cash Position | 2,134 | 1,896 | 1,706 | 1,845 | 1,810 |
| End Cash Position | 2,542 | 2,134 | 1,896 | 1,706 | 1,845 |
| Net Cash Flow | $408 | $238 | $190 | $-139 | $35 |
| Free Cash Flow | |||||
| Operating Cash Flow | 881 | 1,040 | 353 | 241 | 132 |
| Capital Expenditure | -18 | -342 | -55 | -99 | -67 |
| Free Cash Flow | 863 | 699 | 297 | 142 | 65 |